According to the Jerusalem Post, a team of Israeli scientists claim that a cure for cancer is within their reach and they will have it within a year. The team, led by Ilan Morad, the CEO of Accelerated Evolution Biotechnologies, believes they have what they call the first “complete” cure for cancer. They describe it as being akin to an antibiotic for cancer cells. It’s called MuTaTo which stands for Multi-Target Toxin (MTT).
Until now, different types of cancers and different locations for tumors have been treated like different diseases. Treatments for the different cancer diagnosis vary widely depending on the area affected and the nature of the tumor. Those who search for cures and new treatments rarely- if ever- talk about curing cancer in its totality using a universal treatment- until now.
MTT uses numerous peptides that target cancer cells and a toxin that is specifically formulated to weaken and disrupt cancer cells. Because the cancer cells would be killed directly, just as other infections would be killed by antibiotic, patients would be able to stop taking other treatments.
The chairman of the board for Accelerated Evolution Biotechnologies, Dan Aridor said, “We believe we will offer in a year’s time a complete cure for cancer. Our cancer cure will be effective from Day One, will last a duration of a few weeks and will have no or minimal side effects at a much lower cost than most other treatments on the market.”
His claim about the side effects is a big deal. Today, patients diagnosed with aggressive and hard to reach cancers take a melange of chemical and radiological treatments that are poison to the cancer- and to the patient. Sometimes, these treatments do more harm than good and some have likened it to shooting into a crowd of hostages trying to kill a terrorist.
What’s more, MTT was also designed to work in spite of adaptive changes that occur in cancer cells as a tumor grows. This is a problem that impedes the progress of science toward cure for many dreaded diseases. Possibly the most famous mutating deadly disease is HIV/AIDS, which- without advanced treatments- compromises the immune system, leading to the patient eventually being overwhelmed by a myriad of other illnesses. The primary reason effective treatments for AIDS took so long to find is that the virus mutates very rapidly. An effective treatment now, would become useless in just a few weeks.
The persistent and resilient nature of cancer can be attributed to its ability to rapidly mutate, change, and adapt. But according to Ilan Morad, “The researchers made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.”
MTT’s developers say that treatments will be able to be personalized. Patients will be given a cocktail of molecules that is specifically tailored to attack the type of cancer diagnosed.
Current cancer treatments are far more controversial than mainstream medicine lets on. Accepted treatments are believed to exacerbate cancer in many cases, while simultaneously weakening the patient’s resistance to the disease. If the team in Israel is right, many of these problems will become things of the past. Our question is, how far will the medical industry allow this new treatment to progress when the cancer industrial complex remains a multi-billion dollar industry?
The International Agency for Research on Cancer reports that in 2018, approximately 17 million new cancer cases were diagnosed and over 9.5 million people died from cancer globally. The American Cancer Society expects those numbers to grow dramatically by the year 2040.
